There are 2934 resources available
From trials to practice: The possible future of I-O in Gastric/GEJ cancer
Presenter: Kohei Shitara
Session: Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers
Resources:
Webcast
Panel discussion and audience Q&A
Presenter: Ian Chau
Session: Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers
Resources:
Webcast
Introduction: Welcome to the future?
Presenter: Joaquim Bellmunt
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
The path to now: How did the current management of advanced urothelial carcinoma develop?
Presenter: Shahrokh F. Shariat
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
What is today’s understanding of the molecular landscape of advanced urothelial carcinoma?
Presenter: Eva Comperat
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
How could targeted therapies influence the management landscape?
Presenter: Yohann Loriot
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
Can the molecular biology knowledge be integrated into the clinical practice today?
Presenter: Arlene Siefker-Radtke
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
Advanced urothelial carcinoma 2.0: Are we ready for a paradigm shift? Closing remarks
Presenter: Maria De Santis
Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Integrating precision medicine: Are we ready for a paradigm shift in advanced urothelial carcinoma?
Resources:
Webcast
Welcome and introduction
Presenter: Thomas Powles
Session: Bristol-Myers Squibb - Long-term experience and survival: An overview of I-O therapy in RCC and future research in GU cancers
Resources:
Webcast
Welcome and introduction
Presenter: Eva Muñoz-Couselo
Session: Bristol Myers-Squibb - How immuno-oncology has changed the melanoma treatment landscape
Resources:
Webcast